Daily Archives: 12/01/2011

CI & Patent News 12/01/2011

1) Sandoz announces phase II clinical trial for biosimilar version of leading monoclonal antibody rituximab “…. But Novartis’s decision will see highly unusual direct competition between the two Swiss pharmaceutical groups, which are among the world’s leaders by sales….” (FT) 2) Vertex maintains … Continue reading

Posted in Daily interesting IP news, Patent case | Leave a comment